SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-21-000275
Filing Date
2021-01-27
Accepted
2021-01-27 16:02:39
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 REGISTRATION STATEMENT cns_s3.htm S-3 279748
2 FORM OF UNSUBORDINATED INDENTURE cns_ex0401.htm EX-4.1 512256
3 FORM OF SUBORDINATED INDENTURE cns_ex0402.htm EX-4.2 570828
4 OPINION OF SCHIFF HARDIN LLP cns_ex0500.htm EX-5 29296
5 CONSENT OF MALONEBAILEY, LLP cns_ex2301.htm EX-23.1 2664
  Complete submission text file 0001683168-21-000275.txt   1395781
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252471 | Film No.: 21559722
SIC: 2834 Pharmaceutical Preparations